University of Alabama at Birmingham Hospital
Birmingham, Alabama 35295
11 studies enrolling now · 32 studies all time
What they study most
Advanced Solid Tumor, Allan-Herndon-Dudley Syndrome, Anesthesia, B Cell Lymphoma, B-cell Malignancy, Breast Cancer, COPD, Cardiac Surgery, Castration Resistant Prostatic Cancer, Chronic Lymphocytic Leukemia, Colorectal Cancer, Congenital Heart Disease
Studies at this site
- A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma — Recruiting now
- An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors — Recruiting now
- A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies — Recruiting now
- A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — Recruiting now
- A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
- A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL) — Recruiting now
- A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors — Recruiting now
- A Study to Evaluate Solrikitug in Participants With COPD (ZION) — Recruiting now
- Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) — Recruiting now
- SPHERE Per-AF Post-Approval Study — Running, not enrolling
- Signatera Assessment in Early-Stage Endometrial Cancer — Starting soon
- Harmony TPV Post-Approval Study — Running, not enrolling
- Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease — Running, not enrolling
- Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency — Available (expanded access)
- Optimize PRO Study — Completed
- Comparison of Procedural Sedation in TEE — Completed
- Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
- Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma — Running, not enrolling
- A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours — Stopped early
- Transcranial Direct Current Stimulation for Post-stroke Motor Recovery — Completed
- DISSECT-N Post Market Data Collection Registry — Completed
- The Effect of Guanfacine on Delirium in Critically Ill Patients — Completed
- Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
- Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening — Completed
- A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation — Stopped early
- QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery — Stopped early
- Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis — Completed
- Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage — Stopped early
- Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II) — Completed
- Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness — Completed
- (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF — Stopped early
- Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects — Completed